These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 7801988)

  • 21. Stability of metoprolol tartrate in 5% dextrose injection or 0.9% sodium chloride injection.
    Belliveau PP; Shea BF; Scavone JM
    Am J Hosp Pharm; 1993 May; 50(5):950-2. PubMed ID: 8506875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.
    McGuire TR; Narducci WA; Fox JL
    Am J Hosp Pharm; 1993 Jul; 50(7):1410-4. PubMed ID: 8362872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compatibility of cefoperazone sodium and cimetidine hydrochloride in 5% dextrose injection.
    Lee DK; Wang DP; Lee A
    Am J Hosp Pharm; 1991 Jan; 48(1):111-3. PubMed ID: 2000866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability of amiodarone hydrochloride in admixtures with other injectable drugs.
    Campbell S; Nolan PE; Bliss M; Wood R; Mayersohn M
    Am J Hosp Pharm; 1986 Apr; 43(4):917-21. PubMed ID: 3706337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biliary elimination and hepatic disposition of an association of piperacillin and tazobactam: experimental evaluation.
    Brogard JM; Caro-Sampara F; Westphal JF; Blickle JF; Jehl F
    Drugs Exp Clin Res; 1994; 20(6):247-55. PubMed ID: 7758397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability and compatibility of methylprednisolone sodium succinate and cimetidine hydrochloride in 5% dextrose injection.
    Strom JG; Miller SW
    Am J Hosp Pharm; 1991 Jun; 48(6):1237-41. PubMed ID: 1858803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability of vancomycin hydrochloride in 5% dextrose and 0.9% sodium chloride injections.
    Das Gupta V; Stewart KR; Nohria S
    Am J Hosp Pharm; 1986 Jul; 43(7):1729-31. PubMed ID: 3752110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability of ranitidine hydrochloride with ondansetron hydrochloride or fluconazole during simulated Y-site administration.
    Pompilio FM; Fox JL; Inagaki K; Burm JP; Jhee S; Gill MA
    Am J Hosp Pharm; 1994 Feb; 51(3):391-4. PubMed ID: 8160697
    [No Abstract]   [Full Text] [Related]  

  • 29. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visual and absorbance analyses of admixtures containing vancomycin and piperacillin-tazobactam at commonly used concentrations.
    O'Donnell JN; Venkatesan N; Manek M; Rhodes NJ; Scheetz MH
    Am J Health Syst Pharm; 2016 Feb; 73(4):241-6. PubMed ID: 26843502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compatibility of esmolol hydrochloride with morphine sulfate and fentanyl citrate during simulated Y-site administration.
    Karnatz NN; Wong J; Kesler H; Baaske DM; Speicher ER
    Am J Hosp Pharm; 1988 Feb; 45(2):368-71. PubMed ID: 2896460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability and compatibility of minocycline hydrochloride and rifampin in intravenous solutions at various temperatures.
    Pearson SD; Trissel LA
    Am J Hosp Pharm; 1993 Apr; 50(4):698-702. PubMed ID: 8470688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability of Ranitidine Hydrochloride with Cefazolin Sodium, Cefbuperazone Sodium, Cefoxitin Sodium and Cephalothin Sodium during Simulated Y-Site Administration.
    Inagaki K; Miyamoto Y; Kurata N; Nakane S; Gill MA; Nishida M
    Int J Pharm Compd; 2000; 4(2):150-3. PubMed ID: 23985950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of clindamycin phosphate with aztreonam, ceftazidime sodium, ceftriaxone sodium, or piperacillin sodium in two intravenous solutions.
    Marble DA; Bosso JA; Townsend RJ
    Am J Hosp Pharm; 1986 Jul; 43(7):1732-6. PubMed ID: 3529949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability of concentrated trimethoprim-sulfamethoxazole admixtures.
    Jarosinski PF; Kennedy PE; Gallelli JF
    Am J Hosp Pharm; 1989 Apr; 46(4):732-7. PubMed ID: 2785757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compatibility of verapamil hydrochloride with penicillin admixtures during simulated Y-site injection.
    Thompson DF; Stiles ML; Allen LV; Tu YH
    Am J Hosp Pharm; 1988 Jan; 45(1):142-5. PubMed ID: 3348228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability of cefazolin sodium in various artificial tear solutions and aqueous vehicles.
    Ahmed I; Day P
    Am J Hosp Pharm; 1987 Oct; 44(10):2287-90. PubMed ID: 3687969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compatibility and stability of ranitidine hydrochloride with six cephalosporins during simulated y-site administration.
    Inagaki K; Kambara M; Mizuno M; Okuda J; Gill MA; Nishida M
    Int J Pharm Compd; 1998; 2(4):318-21. PubMed ID: 23989642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitation and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC.
    Arzuaga A; Isla A; Gascón AR; Maynar J; Martín A; Solinís MA; Toral D; Pedraz JL
    Biomed Chromatogr; 2005 Oct; 19(8):570-8. PubMed ID: 15828066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability of bupivacaine hydrochloride in polypropylene syringes.
    Jones JW; Davis AT
    Am J Hosp Pharm; 1993 Nov; 50(11):2364-5. PubMed ID: 8266964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.